Understand the source comparison
KPV Wound Healing Protocol Dosage Timing: Comparison
Dosing schedule 200–500mcg every 12 hours (8am/8pm) 600–1000mcg once daily (morning) 200–300mcg every 8 hours (7am/3pm/11pm) Twice-daily at 12-hour intervals is optimal. Balances receptor occupancy with practical compliance Receptor occupancy pattern Sustained
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Dosing schedule
- 200–500mcg every 12 hours (8am/8pm)
- 600–1000mcg once daily (morning)
- 200–300mcg every 8 hours (7am/3pm/11pm)
- Twice-daily at 12-hour intervals is optimal. Balances receptor occupancy with practical compliance
- Receptor occupancy pattern
- Sustained above threshold 20–22 hours/day
- High peak for 6–8 hours, then drops below threshold for 16+ hours
- Excellent coverage but impractical for most patients
- Once-daily creates trough period where inflammation rebounds; every-8-hours is theoretically superior but adherence failure rate exceeds 60%
- Practical adherence rate
- 85–90% in research cohorts
- 70–75% (patients skip or delay second dose frequently)
- 40–50% (middle-of-night injection is compliance barrier)
- Adherence matters more than theoretical optimization. Twice-daily fits real-world schedules
- Inflammatory cytokine suppression
- Consistent NF-κB inhibition throughout dosing day
- Partial suppression. Rebounds during trough
- Maximal suppression if adherence maintained
- Twice-daily achieves 80–85% of maximal suppression with 2× better adherence than every-8-hours
- Tissue healing velocity (weeks to 50% wound closure)
- 3.2–3.8 weeks in chronic wound models
- 4.5–5.2 weeks (trough periods slow healing)
- 2.8–3.2 weeks (when perfectly adhered to)
- Real-world healing outcomes favor twice-daily because consistent moderate receptor occupancy outperforms intermittent high occupancy